12 Everolimus Added to Exemestane Reduced Bone Markers in Postmenopausal Women with Advanced Breast Cancer (ABC): the BOLERO-2 Trial
European Journal of Cancer（2012）
Key words
advanced breast cancer,everolimus,breast cancer,reduced bone markers,postmenopausal women
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined